Skip to main content

Peer Review reports

From: Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial

Original Submission
8 Jan 2019 Submitted Original manuscript
25 Mar 2019 Author responded Author comments - Juan Villar
Resubmission - Version 2
25 Mar 2019 Submitted Manuscript version 2
Publishing
10 May 2019 Editorially accepted
15 Jul 2019 Article published 10.1186/s13063-019-3423-3

You can find further information about peer review here.

Back to article page